← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Xenobiotic Laboratories, Inc.
Plainsboro, NJ
$2,671,483
Total funding
2
Grants
Funding over time
peak $733.4K · FY2013–20$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,671,483 · 2
By mechanism
N01$2,671,483 · 2
Investigators at Xenobiotic Laboratories, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Analytical Services Center for Medications Development Program$733,449
N01 · FY2014 · DA
IGF::OT::IGF : Analytical Services Center for Medications Development Program. September 15, 2013 - September 14, 2018. N01DA-13-8920.PURPOSE: To obligate funds to fully fund performance under T$633,945
N01 · FY2016 · DA
Analytical Services Center for Medications Development Program$322,774
N01 · FY2015 · DA
Analytical Services Center for Medications Development Program$281,475
N01 · FY2013 · DA
IGF::OT::IGF : Analytical Services Center for Medications Development Program. September 15, 2013 - September 14, 2018. N01DA-13-8920.PURPOSE: To obligate funds to fully fund performance under T$278,157
N01 · FY2017 · DA
ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM. SEPTEMBER 25, 2019 - MARCH 24, 2021. N01DA-19-8938. TASK ORDER 2 - 75N95019F00089.$214,791
N01 · FY2019 · DA
FY20. ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM. TASK ORDER 3 -75N95020F00192. POP - 09.24.2020 TO 09.23.2022.$131,331
N01 · FY2020 · DA
ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM. SEPTEMBER 25, 2019 - SEPTEMBER 24, 2020. N01DA-19-8938. TASK ORDER 1 - 75N95019F00088.$67,200
N01 · FY2019 · DA
IGF::OT::IGF : TASK ORDER 10. ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM. SEPTEMBER 15, 2013 - SEPTEMBER 14, 2018. N01DA-13-8920.PURPOSE: TO EXTEND THE PERIOD OF PERFORMANCE FOR$8,361
N01 · FY2018 · DA